Drug sensitivity testing platforms for gastric cancer diagnostics

Area of Science:

• Oncology
• Genomics
• Pathology

Background:

• Gastric cancer diagnostics traditionally relies on histomorphology.
• Molecular and genomic techniques are increasingly used in diagnostics.
• Personalised drug sensitivity testing is an emerging field for gastric cancer.

Purpose of the Study:

• To review current personalised drug sensitivity testing platforms for gastric cancer.
• To discuss challenges hindering the clinical adoption of these assays.

Main Methods:

• Literature review of personalised drug sensitivity testing platforms.
• Analysis of challenges in clinical implementation for gastric cancer.

Main Results:

• Overview of diverse personalised drug sensitivity testing platforms available.
• Identification of key barriers to the integration of these tests into routine clinical practice.

Conclusions:

• Personalised drug sensitivity testing holds significant promise for tailoring gastric cancer treatment.
• Overcoming challenges is crucial for the successful clinical adoption of these advanced diagnostic tools.